{"id":"W2939770857","doi":"10.1016/s0140-6736(18)32487-5","title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","year":2019,"lang":"en","type":"article","venue":"The Lancet","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":1859,"is_retracted":false,"has_abstract":false,"ca_institutions":"Nova Scotia Cancer Centre; McGill University Health Centre; Juravinski Cancer Centre; Surrey Place Centre; Positive Living North; London Health Sciences Centre","funders":"Ontario Institute for Cancer Research","keywords":"SABR volatility model; Ablative case; Medicine; Radiation therapy; Standard of care; Open label; Palliative care; Radiosurgery; Randomized controlled trial; Surgery","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}